Safety of Anti-TNF Therapies in Immune-Mediated Inflammatory Diseases: Focus on Infections and Malignancy

Drug Development Research - United States
doi 10.1002/ddr.21285
Full Text
Abstract

Available in full text

Categories
Drug Discovery
Date
Authors
Publisher

Wiley

Related search

Genetics of Immune-Mediated Inflammatory Diseases

Clinical and Experimental Immunology
AllergyImmunology
2018English

The Gut Microbiota in Immune-Mediated Inflammatory Diseases

Frontiers in Microbiology
Microbiology
2016English

Heme Cytotoxicity and the Pathogenesis of Immune-Mediated Inflammatory Diseases

Frontiers in Pharmacology
Pharmacology
2012English

Brazilian Recommendations on the Safety and Effectiveness of the Yellow Fever Vaccination in Patients With Chronic Immune-Mediated Inflammatory Diseases

Advances in Rheumatology
Rheumatology
2019English

Therapies for Inflammatory Diseases

The Journal of Auto-Nomic Nervous System
1971English

Tolerogenic Dendritic Cells for Therapy of Immune-Mediated Inflammatory Diseases

2012English

Genomics of Immune Diseases and New Therapies

Annual Review of Immunology
AllergyImmunology
2016English

Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases

Frontiers in Immunology
AllergyImmunology
2018English

Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-Analysis

Gastroenterology
HepatologyGastroenterology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy